Pipeline

Clinical Trials

A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of iCo-007 Intravitreal Injection in Subjects with Diffuse Diabetic Macular Edema is currently in progress.

If you are a physician or a patient interested in participating in this study, please contact us at: .(JavaScript must be enabled to view this email address)

Further information about the trial is available at http://clinicaltrials.gov/ct2/show/NCT00886808.